We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Thirty‐day readmission in patients undergoing head and neck microvascular reconstruction.
- Authors
Graboyes, Evan M.; Schrank, Travis P.; Worley, Mitchell L.; Momin, Suhael R.; Day, Terry A.; Huang, Andrew T.
- Abstract
Abstract: Background: Characteristics of 30‐day unplanned readmissions after head and neck microvascular reconstruction remain poorly understood. Methods: We conducted a retrospective cohort of patients who underwent head and neck microvascular reconstruction between 2010 and 2015. Results: The 30‐day unplanned readmission rate was 13.0% (64/493). The most common readmission diagnoses were dehiscence, surgical site infection, or fistula (45.3%; n = 29). Of the readmissions, 46.9% (30/64) occurred within 7 days of discharge from the hospital. Risk factors for readmission on multivariable analysis included body mass index (BMI) < 21 kg/m (odds ratio [OR] 2.47; 95% confidence interval [CI] 1.36‐4.47), primary site of oropharynx (OR 1.66; 95% CI 1.17‐6.06), hypopharynx/larynx (OR 3.66; 95% CI 1.70‐7.88), or sinonasal/skull base (OR 4.07; 95% CI 1.43‐11.55), and fistula during the index hospitalization (OR 2.98; 95% CI 1.22‐7.24). Conclusion: More than 1 in 10 patients undergoing head and neck microvascular reconstruction has a 30‐day unplanned readmission, most commonly related to wound complications. Further efforts are needed to determine optimal 30‐day unplanned readmission reduction strategies.
- Subjects
PATIENT readmissions; HEAD &; neck cancer treatment; MICROCIRCULATION disorders; POSTOPERATIVE care; SURGICAL wound dehiscence; SURGICAL site infections; FISTULA; HOSPITAL admission &; discharge
- Publication
Head & Neck, 2018, Vol 40, Issue 7, p1366
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.25107